Equillium Shares Are Trading Lower After the Company Announced Ono Pharmaceutical Has Made the Business Decision to Allow the Expiration of Its Option to Acquire Equillium's Rights to Itolizumab
Equillium Shares Are Trading Lower After the Company Announced Ono Pharmaceutical Has Made the Business Decision to Allow the Expiration of Its Option to Acquire Equillium's Rights to Itolizumab
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.